The Propoxyphene Hydrochloride Capsu, cataloged under National Stock Number 6505-01-023-1037, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Eli Lilly and Company. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 4 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-023-1037 |
| Primary Part Number | NDC00002-0803-02 |
| Item Name | Propoxyphene Hydrochloride Capsu |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Eli Lilly and Company |
| Status | ACTIVE |
| Administration | ORAL |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 100.000 |
| Capsule Type | SOFT |
| Active Medicament Medicinal Strength | 65.000 MILLIGRAMS PROPOXYPHENE HYDROCHLORIDE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00002-0803-02 PRIMARY | Eli Lilly and Company (USA) |
| NDC00182-0698-01 PRIMARY | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
| 02660 PRIMARY | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
| NDC02-0803-02 PRIMARY | Eli Lilly and Company (USA) |
NSN 6505-01-023-1037 is a Propoxyphene Hydrochloride Capsu, manufactured by Eli Lilly and Company, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-023-1037 has 4 manufacturer part numbers on file: NDC00002-0803-02 (Eli Lilly and Company), NDC00182-0698-01 (Goldline Laboratories, Inc. Dba Goldline Laboratories), 02660 (Goldline Laboratories, Inc. Dba Goldline Laboratories), NDC02-0803-02 (Eli Lilly and Company).
Key specifications for NDC00002-0803-02: Administration: ORAL; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Special Features: COLOR LIGHT-PINK OPAQUE;CAPSULE CONTENT FORM:CRYSTALLINE POWDER. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.